




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Cardiac Surgery</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=7477ae68-a2db-444b-a0b2-e21d88347930</link>
        <description>Clinical Topic Feed: Cardiac Surgery</description>
        <language>en</language>

        

                <item>
                    <title>JACC Journals Science at ESC Heart Failure Congress 2026</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/JACC-Journals-Science-at-ESC-Heart-Failure-Congress-2026</link>                    <description>Findings from several studies presented at ESC Heart Failure Congress 2026 in Barcelona, Spain, were simultaneously published in JACC and JACC: Heart Failure, covering topics like arrhythmic burden in cardiac amyloidosis (CA), stroke and bleeding risk in CA...</description>
                    <pubdate>1778607960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Venous Flow, Hepatic Woe: Fontan-Associated Liver Disease</title>
<link>/Education-and-Meetings/Patient-Case-Quizzes/2026/05/05/16/43/Venous-Flow-Hepatic-Woe</link>                    <description>A 31-year-old woman with hypoplastic left heart syndrome status post extracardiac Fontan procedure presents to the clinic with worsening exercise capacity, fatigue, abdominal swelling, early satiety, weight loss, and diarrhea.</description>
                    <pubdate>1778594220000</pubdate>
                    <category>Educational Activities</category>
                </item>
                <item>
                    <title>&#226;€&#175;Eagle&#226;€™s Eye View: PCI Vs. CABG In Patients With Unprotected Left Main CAD: NOBLE Study </title>
<link>/Latest-in-Cardiology/Articles/2026/05/06/13/43/eagles-eye-view-06may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle&#226;€&#175;looks at the NOBLE trial evaluating whether percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is best for patients with unprotected left main coronary artery disease (CAD).</description>
                    <pubdate>1778075040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Joint Statement from the Society for Cardiovascular Angiography &amp; Interventions, American College of Cardiology, and Society of Thoracic Surgeons on Aortic Valve Replacement Decision-Making</title>
<link>/Latest-in-Cardiology/Articles/2026/05/01/22/49/Joint-Statement</link>                    <description>The Society for Cardiovascular Angiography &amp; Interventions (SCAI), American College of Cardiology (ACC), and Society of Thoracic Surgeons (STS), on May 1, released the following joint statement in response to recent media coverage about Transcatheter Aortic Valve Replacement (TAVR) and Surgical Aortic Valve Replacement (SAVR):...</description>
                    <pubdate>1777679520000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC Featured Jobs For May 2026</title>
<link>/Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs</link>                    <description>Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!</description>
                    <pubdate>1777629480000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>NOBLE: Is PCI Equally as Safe as CABG For Patients With Unprotected Left Main CAD?</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/04/28/20/06/noble</link>                    <description>No significant difference was observed in all-cause mortality at 10 years between PCI and CABG in patients with unprotected left main coronary artery disease (CAD) and no additional complex lesions, according to the final results of the NOBLE study published April 4 in The Lancet.</description>
                    <pubdate>1777412340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC.26 Structural Intervention Trials Offer Viable Options</title>
<link>/Latest-in-Cardiology/Articles/2026/04/21/15/23/ACC26-Structural-Intervention-Trials-Offer-Viable-Options</link>                    <description>Late-breaking clinical trials presented at ACC.26 focusing on structural interventions included the PROTECT H2H trial comparing two embolic protection devices (EPDs) in patients undergoing transcatheter aortic valve implantation (TAVI), the PRO-TAVI trial comparing a strategy of routine PCI with a deferred approach...</description>
                    <pubdate>1776939000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Can BP Control Trajectories Lead to Better CV Outcomes?</title>
<link>/Latest-in-Cardiology/Articles/2026/04/22/13/48/eagles-eye-view-22apr2026</link>                    <description>In this week&#226;€™s Eagle&#39;s Eye View, Dr. Eagle examines early surgery for asymptomatic patients with severe aortic stenosis.</description>
                    <pubdate>1776865800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Does Early Surgery For Patients With Severe AS Lower CV Mortality Risk?</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/04/15/17/20/Does-Early-Surgery</link>                    <description>Early surgical aortic valve replacement (SAVR) led to a lower incidence of operative mortality or cardiovascular-related death at 10 years in patients with very severe aortic stenosis (AS), according to an extended follow-up of the RECOVERY trial published March 25 in NEJM.</description>
                    <pubdate>1776358260000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Transcatheter Aortic Valve Implantation: Durability and Management of Valve Failure</title>
<link>/Latest-in-Cardiology/Articles/2026/04/13/18/35/Transcatheter-Aortic-Valve-Implantation</link>                    <description>Transcatheter aortic valve implantation (TAVI) has become a cornerstone therapy for patients with severe aortic stenosis across a wide spectrum of clinical presentations and surgical risk. Initially reserved for patients at prohibitive or high surgical risk, TAVI is now widely adopted in populations at intermediate and low risk...</description>
                    <pubdate>1776119820000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>